Robert Schneider, Ph.D., is the Albert Sabin Professor of Molecular Pathogenesis and co-director of the Breast Cancer Research Program at NYU School of Medicine. His lab performs basic, translational and…
From Patient Mutations to Small Molecules: Lessons Learned from Protein Phosphatase 2A
Dr. Gouthma Narla earned his B.S. in biology and economics from Santa Clara University in California and his MD, Ph.D. and performed his residency at Mount Sinai School of Medicine…
Hongmin Chen joins WARF Therapeutics
Chen to head biology for program aiming to produce preclinical candidates CONTACT: Jeanan Yasiri Moe Director of Strategic Communications [email protected] | (608) 960-9892 MADISON, Wis. – WARF Therapeutics, the multimillion-dollar…
WARF Therapeutics fall 2021 call for proposals
Program proposal deadline October 8 CONTACT: Jeanan Yasiri Moe Director of Strategic Communications [email protected] | (608) 960-9892 MADISON, Wis. – WARF Therapeutics collaborates with researchers to advance their work closer…
WARF Therapeutics spring 2021 call for proposals
Program proposal deadline April 5 CONTACT: Jeanan Yasiri Moe Director of Strategic Communications [email protected] | (608) 960-9892 MADISON, Wis. – WARF Therapeutics collaborates with researchers to advance their work closer…
WARF Therapeutics 2020 call for fall proposals
CONTACT: Jacqui Fuller, Strategic Communications and Marketing Manager [email protected] | 608.960.9881 Fall WARF Therapeutics (WT) Program Proposal Deadline: October 15 MADISON, Wis. – WARF Therapeutics encourages researchers working on a…
WARF Therapeutics spring proposal deadline
Spring WARF Therapeutics (WT) Program Proposal Deadline: April 15 If you are a researcher working on a novel biological target, WARF Therapeutics may be able to help advance your work…
Industry leaders join WARF Therapeutics Advisory Board
CONTACT: Jeanan Yasiri Moe, Director of Strategic Communications [email protected] | 608.960.9892 Leaders from Celgene, Third Rock Ventures and other top pharma companies will help guide new drug discovery initiative at…